Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jared Johnson

Orthopaedic Surgery Boise, ID Medical Doctor

NPI 1891982559 CMS profile 267257

8854 W Emerald St Ste 102, Boise, ID 83704

Open in the dashboard

General payments

$82,127

245 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jared Johnson of Boise, ID is reported in the CMS Open Payments database as having received $82,127 across 245 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $57,333 64
2024 General $10,729 51
2023 General $3,419 34
2022 General $414 25
2021 General $2,232 26
2020 General $5,592 24
2019 General $2,409 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jared Johnson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jared Johnson were reported at $57,333. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Jared Johnson Orthopaedic Surgery median Middle half National median
2019 $2,409 $644 $140–$2,844 $163
2020 $5,592 $312 $75–$1,860 $114
2021 $2,232 $520 $117–$2,495 $132
2022 $414 $598 $128–$2,731 $149
2023 $3,419 $461 $128–$2,264 $160
2024 $10,729 $497 $134–$2,475 $164
2025 $57,333 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $62,142 194 payments
  2. Arthrex, Inc. $9,981 20 payments
  3. Steelhead Surgical Inc $9,607 22 payments
  4. Sawtooth Surgical Solutions Inc $121 2 payments
  5. Catalyst OrthoScience $81 1 payment
  6. DePuy Synthes Sales Inc. $79 3 payments
  7. Curonix LLC $70 1 payment
  8. Flexion Therapeutics, Inc. $31 1 payment
  9. Globus Medical, Inc. $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $47,966 15 payments
  2. Travel and Lodging $15,147 33 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,000 4 payments
  4. Food and Beverage $6,137 187 payments
  5. Education $3,877 6 payments
Products named General payments · program years 2019–2025
  1. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $55,516 62 payments
  2. AEQUALIS PERFORM $29,112 4 payments
  3. AEQUALIS PERFORM REVERSED $29,090 6 payments
  4. SIMPLICITI $19,668 2 payments
  5. AEQUALIS $13,599 6 payments
  6. TORNIER PERFORM REVERSED GLENOID $5,449 25 payments
  7. TORNIER PERFORM REVERSED AUGMENTED GLENOID $641 18 payments
  8. MAKO $572 3 payments
  9. REUNION Trauma & Extremeties $474 34 payments
  10. REUNION Trauma & Extremeties $279 25 payments
  11. Other $1,486 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

20

Median for Orthopedic Surgery: 203

Drug cost

$24

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 20 $24

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 16 billing codes

Paid by Medicare

$74,650

Of which drugs: $41

Medicare patients

147

Average age 72

Services billed

438

75 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Depression 27%
Chronic kidney disease 19%
Diabetes 17%
Cancer 15%
Ischemic heart disease 12%
Osteoporosis 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 13 56 $41

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

245 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Idaho

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record